Acute Reperfusion Therapies and Prognosis in Nonagenarian Stroke Patients
Age is a crucial factor affecting prognosis after stroke with a turning point at 90 years old. However, age alone should not be a limiting factor for treatment decision. Despite higher mortality and poorer functional prognosis overall, some nonagenarians may benefit from reperfusion therapies.
Authors
- Laurent Spelle (ORCID: https://orcid.org/0000-0002-6748-8528)
- Mariana Sarov-Rivière
- Olga Lainé
- Tom Pujol
- Christian Denier (ORCID: https://orcid.org/0000-0002-2087-5563)
- Alexandra Rouquette (ORCID: https://orcid.org/0000-0002-2473-1719)
- Claude Deschamps
- Nicolas Legris
- Anne-Laure Vétillard
- Claire Ancelet (ORCID: https://orcid.org/0000-0002-0205-5721)
- Claire Peillet (ORCID: https://orcid.org/0000-0001-7523-6147)
- Nicoletta Brunetti
- Louise Bicart‐Sée
- Olivier Chassin
- Élodie Baudry
- Laura Venditti-Maillet
Institutions
- Inserm (FR)
- Université Paris-Saclay (FR)
- Assistance Publique – Hôpitaux de Paris (FR)
- Centre de recherche en Epidémiologie et Santé des Populations (FR)
- Bicêtre Hospital (FR)
Publication Details
- Journal
- Gerontology
- Published
- 2024-10-31
- DOI
- https://doi.org/10.1159/000540872
- Citations
- 2
- Primary Topic
- Acute Ischemic Stroke Management
- Type
- article
- Field-Weighted Citation Impact
- 0.77